Preoperative bacterial culture can predict severe pneumonia in patients receiving esophagectomy.


Journal

Fukushima journal of medical science
ISSN: 2185-4610
Titre abrégé: Fukushima J Med Sci
Pays: Japan
ID NLM: 0374626

Informations de publication

Date de publication:
18 Aug 2022
Historique:
pubmed: 8 8 2022
medline: 20 8 2022
entrez: 7 8 2022
Statut: ppublish

Résumé

Postoperative pneumonia is one of the major complications after esophagectomy. The aim of this study was to determine whether bacterial cultures before esophagectomy could predict occurrence of postoperative pneumonia and help treatment strategies for postoperative pneumonia. Sixty-nine patients who underwent subtotal esophagectomy at Fukushima Medical University Hospital between January 2017 and May 2021 were included in this study. We collected sputum, oral, and/or nasopharyngeal swabs for bacterial culture preoperatively from all patients and from those who were suspected of postoperative pulmonary infections. We compared cultured pathogenic bacteria obtained preoperatively and postoperatively from patients who developed postoperative pneumonia, and investigated their association with incidence of postoperative pneumonia. Postoperative pneumonia occurred in 22 of 69 patients (31%), including 13 cases of severe pneumonia with a Clavien-Dindo classification of grade IIIa or higher. Multivariate analysis revealed that longer operative duration (for 30 minutes increase;odds ratio 1.27, 95% CI 1.01-1.51, p=0.039) and positivity for preoperative bacterial culture (odds ratio 5.03, 95% CI 1.31-19.2, p=0.018) were independent risk factors for severe postoperative pneumonia, but not for all incidences of postoperative pneumonia. Of note, in only 5 of the 22 patients with pneumonia, the same pathogenic species were detected preoperatively and after the onset of pneumonia. Our results imply that preoperative bacterial culture may be useful to predict severe postoperative pneumonia. However, it may not be useful in determining pathogenic bacteria responsible for postoperative pneumonia.

Sections du résumé

BACKGROUND BACKGROUND
Postoperative pneumonia is one of the major complications after esophagectomy. The aim of this study was to determine whether bacterial cultures before esophagectomy could predict occurrence of postoperative pneumonia and help treatment strategies for postoperative pneumonia.
METHODS METHODS
Sixty-nine patients who underwent subtotal esophagectomy at Fukushima Medical University Hospital between January 2017 and May 2021 were included in this study. We collected sputum, oral, and/or nasopharyngeal swabs for bacterial culture preoperatively from all patients and from those who were suspected of postoperative pulmonary infections. We compared cultured pathogenic bacteria obtained preoperatively and postoperatively from patients who developed postoperative pneumonia, and investigated their association with incidence of postoperative pneumonia.
RESULTS RESULTS
Postoperative pneumonia occurred in 22 of 69 patients (31%), including 13 cases of severe pneumonia with a Clavien-Dindo classification of grade IIIa or higher. Multivariate analysis revealed that longer operative duration (for 30 minutes increase;odds ratio 1.27, 95% CI 1.01-1.51, p=0.039) and positivity for preoperative bacterial culture (odds ratio 5.03, 95% CI 1.31-19.2, p=0.018) were independent risk factors for severe postoperative pneumonia, but not for all incidences of postoperative pneumonia. Of note, in only 5 of the 22 patients with pneumonia, the same pathogenic species were detected preoperatively and after the onset of pneumonia.
CONCLUSIONS CONCLUSIONS
Our results imply that preoperative bacterial culture may be useful to predict severe postoperative pneumonia. However, it may not be useful in determining pathogenic bacteria responsible for postoperative pneumonia.

Identifiants

pubmed: 35934806
doi: 10.5387/fms.2022-09
pmc: PMC9493340
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-116

Références

Keio J Med. 2019 Mar 25;68(1):17-25
pubmed: 30298826
Dis Esophagus. 2017 Dec 1;30(12):1-9
pubmed: 28881886
Eur J Cardiothorac Surg. 2002 Jul;22(1):23-7; discussion 27-9
pubmed: 12103368
Esophagus. 2021 Oct;18(4):773-782
pubmed: 33993389
J Gastrointest Surg. 2010 Oct;14(10):1492-501
pubmed: 20824375
Geriatr Gerontol Int. 2015 Apr;15(4):417-21
pubmed: 25130073
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Nutr Hosp. 2005 Jan-Feb;20(1):38-45
pubmed: 15762418
Surg Endosc. 2018 Jun;32(6):2852-2858
pubmed: 29273870
Ann Surg Oncol. 2019 Aug;26(8):2580-2586
pubmed: 31144141
Ann Gastroenterol Surg. 2018 Sep 21;3(1):57-64
pubmed: 30697611
Ann Surg. 2014 Aug;260(2):259-66
pubmed: 24743609
Ann Surg. 2012 Feb;255(2):197-203
pubmed: 22173202
Ann Surg. 2016 Aug;264(2):305-11
pubmed: 26670288
Surgery. 2010 Apr;147(4):497-502
pubmed: 20004439
Ann Surg Oncol. 2016 Jun;23(6):2106-14
pubmed: 26753750
World J Gastroenterol. 2013 Oct 21;19(39):6509-14
pubmed: 24151374
Ann Surg. 2020 Dec;272(6):1035-1043
pubmed: 30946087

Auteurs

Akinao Kaneta (A)

Department of Gastrointestinal Tract Surgery, Fukushima Medical University.

Takahiro Sato (T)

Department of Gastrointestinal Tract Surgery, Fukushima Medical University.

Hiroshi Nakano (H)

Department of Gastrointestinal Tract Surgery, Fukushima Medical University.

Takuro Matsumoto (T)

Department of Gastrointestinal Tract Surgery, Fukushima Medical University.

Takeshi Tada (T)

Department of Gastrointestinal Tract Surgery, Fukushima Medical University.

Yohei Watanabe (Y)

Department of Gastrointestinal Tract Surgery, Fukushima Medical University.

Hiroyuki Hanayama (H)

Department of Gastrointestinal Tract Surgery, Fukushima Medical University.

Suguru Hayase (S)

Department of Gastrointestinal Tract Surgery, Fukushima Medical University.

Zenichiro Saze (Z)

Department of Gastrointestinal Tract Surgery, Fukushima Medical University.

Koji Kono (K)

Department of Gastrointestinal Tract Surgery, Fukushima Medical University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH